TGF-β1, TGF-β2, and TGF-β3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro

Journal of Bone and Mineral Research

Volumn 12, Issue 3, 1997, Pages 301-310

  Opperman, Lynne A ^a,c   Nolen, Amber A ^b   Ogle, Roy C ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CRANIAL SUTURE; FETUS; GROWTH CONE; GROWTH REGULATION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OSSIFICATION; OSTEOCYTE; POLYMERASE CHAIN REACTION; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION;

EID: 0030946345     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.3.301     Document Type: Article

References (44)

1. Raisz LG 1965 Bone resorption in tissue culture: Factors influencing the response to parathyroid hormone. J Clin Invest 44:103-116.
2. Raisz LG, Kream BE 1983 Regulation of bone. New Engl J Med 309:29-35, 83-89.
3. Gronowicz G, Woodiel FN, McCarthy M-B, Raisz LG 1989 In vitro mineralization of fetal rat parietal bones in defined serum-free medium: Effect of β-glycerol phosphate. J Bone Miner Res 4:313-324.
4. Baer MJ 1954 Patterns of growth of the skull as revealed by vital staining. Hum Biol 26:80-126.
5. Markens IS 1975 Transplantation of the future coronal suture on the dura mater of 3- to 4-month-old rats. Acta Anat 37:351-370.
6. Johansen VA, Hall SH 1982 Morphogenesis of the mouse coronal suture. Acta Anat 114:58-67.
7. Kokich VG 1986 The biology of sutures. In: Cohen MM (ed.) Craniosynostosis: Diagnosis, evaluation and management. Raven Press, New York, NY, U.S.A., pp. 81-103.
8. Cohen MM Jr 1993 Sutural biology and the correlates of Craniosynostosis. Am J Med Genet 47:581-616.
9. Opperman LA, Sweeney TM, Redmon J, Persing JA, Ogle RC 1993 Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev Dynam 198:312-322.
10. Opperman LA, Passarelli RW, Morgan EP, Reintjes M, Ogle RC 1995 Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro. J Bone Miner Res 10:1978-1987.
11. Opperman LA, Passarelli RW, Nolen AA, Gampper TJ, Lin KL, Ogle RC 1996 Dura mater secretes soluble heparin-binding factors required for cranial suture morphogenesis. In Vitro Cell Dev Biol 32, 10:627-632.
12. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA 1988 Novel regulators of bone formation: molecular clones and activities. Science 242: 1528-1534.
13. Wozney JM 1992 The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 32:160-167.
14. Stein GS, Lian JB 1993 Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblastic phenotype. Endocr Rev 14: 424-442.
15. Centrella M, Horowitz MC, Wozney JM, McCarthy TL 1994 Transforming growth factor-β gene family members and bone. Endocr Rev 15:27-37.
16. ten Dijke P, Iwata KK, Goddard C, Pieler C, Canalis E, McCarthy TL, Centrella M 1990 Recombinant transforming growth factor type β3: Biological activities and receptor-binding properties in isolated bone cells, Mol Cell Biol 10:4473-4479.
17. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI 1991 Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-105.
18. Gehris AL, D'Angelo M, Greene RM 1991 Immunodetection of the transforming growth factors β1 and β2 in the developing murine palate. Int J Dev Biol 35:17-24.
19. 1-induced intramembranous ossification in neonatal rat parietal bone. Bone 14:117-123.
20. 1 modulates bone remodeling in a mineralizing bone organ culture. J Bone Miner Res 8:423-427.
21. Centrella M, Canalis E 1985 Transforming and non-transforming growth factors are present in medium conditioned by fetal rat calvaria. Proc Natl Acad Sci USA 82:7335-7339.
22. Centrella M, Horowitz MC, Wozney JM, McCarthy TL 1994 Transforming growth factor-β gene family members and bone. Endocr Rev 15:27-37.
23. Massagué J, Attisano L, Wrana JL 1994 The TGF-β family and its composite receptors. Trends Cell Biol 4:172-178.
24. Sandberg MT, Vuorio H, Hirvonen K, Alitalo K, Vuorio E 1988 Enhanced expression of TGF-β and c-fos mRNAs in the growth plates of developing human long bones. Development 102:461-470.
25. Opperman LA, Saunders TJ, Bruns DE, Boyd JC, Mills SE, Bruns ME 1992 Estrogen inhibits calbindin-D28k expression in mouse uterus. Endocrinology 130:1728-1735.
26. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-160.
27. Birch MA, Ginty AF, Walsh CA, Fraser WD, Gallagher JA, Bilbe G 1993 PCR detection of cytokines in normal human and pagetic osteoblast-like cells. J Bone Miner Res 8:1155-1162.
28. Roth DA, Bradley JP, Levine JP, McMullen HF, McCarthy JG, Longaker MT 1996 Studies in cranial suture biology: Part II. Role of the dura in cranial suture fusion. Plast Recon Surg 97:693-699.
29. Roth DA, Longaker MT, Breitbart AS, McCarthy JG, Gold LI 1994 The role of transforming growth factor beta-1 in rat cranial suture fusion. 63rd Annual Scientific Meeting ASPRS-PSEF-ASMS, San Diego, California, U.S.A., September, 1994, pp. 39-40.
30. Bellows G, Aubin JE, Heersche JNM, Antosz ME 1986 Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 38:143-154.
31. Jabs EW, Li X, Scott AF, Meyers G, Chen W, Eccles M, Mao J-I, Charnas LR, Jackson CE, Jaye M 1994 Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast receptor 2. Nature Genet 8:275-279.
32. Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S, Winter RM 1994 A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genet 8:269-274.
33. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S 1994 Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nature Genet 8:98-103.
34. Rutland P, Pulleyn LJ, Reardon W, Baraitser M, Hayward R, Jones B, Malcolm S, Winter RM, Oldridge M, Slaney SF, Poole MD, Wilkie AOM 1995 Identical mutations in the FGFR2 gene causes both Pfeiffer and Crouzon syndrome phenotypes. Nature Genet 9:173-176.
35. Wilkie AOM, Slaney SF, Oldridge M, Poole MD, Ashworth GJ, Hockley AD, Hayward RD, David DJ, Pulleyn LJ, Rutland P, Malcolm S, Winter RM, Reardon W 1995 Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nature Genet 9:165-172.
36. Frenkel SR, Grande DA, Collins M, Singh IJ 1990 Fibroblast growth factor in chick osteogenesis. Biomaterials 11:38-40.
37. Frenkel SR, Herskovits MS, Singh IJ 1992 Fibroblast growth factor: Effect on osteogenesis and chondrogenesis in the chick embryo. Acta Anat 145:265-268.
38. Mayahara H, Ito T, Nagai H, Miyajima H, Tsukuda R, Taketomi S, Mizoguchi J, Kato K 1993 In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Fact 9:73-80.
39. Kasperk CH, Wergedal JE, Mohan S, Long DL, Lau KH, Baylink DJ 1990 Interactions of growth factors present in bone matrix with bone cells: Effects on DNA synthesis and alkaline phosphatase. Growth Fact 3:147-158.
40. Shiang R, Thompson LM, Zhu Y-Z, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ 1994 Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335-342.
41. Thomas JT, Un K, Nandedkar M, Camargo M, Cervenka J, Luyten FP 1996 A human chondrodysplasia due to a mutation in a TGF-β superfamily member. Nature Genet 12:315-317.
42. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, Ding J, Ferguson MWJ, Doetschman T 1995 Transforming growth factor-β3 is required for secondary palate fusion. Nature Genet 11:409-414.
43. Boivin GP, O'Toole BA, Ormsby IE, Diebold RJ, Eis MJ, Doetschman T, Kier AB 1995 Animal model: Onset and progression of pathological lesions in transforming growth factor-β1-deficient mice. Am J Pathol 146:276-288.
44. Kulkarni AB, Ward JM, Yaswen L, Mackall CL, Bauer SR, Huh C-G, Gress RE, Karlsson S Animal model: Transforming growth factor-β1 null mice. An animal model for inflammatory disorders. Am J Pathol 146:264-275.